Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 10/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL624870 | 0.95 | MAPT (0.42) | MAP3K12PIK3CAMAPTTHRBPOLB | |
| SCHEMBL624968 | 0.95 | MAP3K12 (0.43) | MAP3K12PIK3CAMAPTTHRB | |
| SCHEMBL625732 | 0.87 | PIK3CA (0.53) | MAP3K12PIK3CA | |
| SCHEMBL626169 | 0.85 | MAP3K12 (0.41) | MAP3K12PIK3CAMAPTTHRB | |
| SCHEMBL624991 | 0.84 | SYK (0.45) | MAP3K12PIK3CA | |
| SCHEMBL625433 | 0.83 | MAPT (0.43) | MAP3K12MAPTTHRBPOLB | |
| SCHEMBL625228 | 0.83 | MAP3K12 (0.46) | MAP3K12PIK3CA | |
| SCHEMBL624866 | 0.83 | PIK3CA (0.46) | MAP3K12PIK3CAMAPTTHRBPOLB | |
| SCHEMBL626620 | 0.82 | MAP3K12 (0.52) | MAP3K12PIK3CA | |
| SCHEMBL624869 | 0.82 | PIK3CA (0.52) | MAP3K12PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |